MARKET

WBA

WBA

Walgreens Boots
NASDAQ

Real-time Quotes | Nasdaq Last Sale

48.02
-1.60
-3.22%
Opening 14:27 09/20 EDT
OPEN
48.99
PREV CLOSE
49.62
HIGH
49.40
LOW
48.01
VOLUME
2.49M
TURNOVER
--
52 WEEK HIGH
57.05
52 WEEK LOW
33.36
MARKET CAP
41.54B
P/E (TTM)
20.73
1D
5D
1M
3M
1Y
5Y
CVS Health to hire 25,000 ahead of flu season, COVID-19 boosters
reuters.com · 7h ago
Former Theranos scientist says Elizabeth Holmes pushed her to validate tests for Walgreens rollout
Former Theranos senior scientist Surekha Gangakhedkar testified on Friday that CEO Elizabeth Holmes pressured the lab to validate blood tests
CNBC.com · 2d ago
Walgreens Boots Alliance (WBA) Stock Moves -0.64%: What You Should Know
Zacks.com · 2d ago
Even Covid-19 Cannot End Disney's Enduring Magic
Photo by pan xiaozhen on Unsplash
Benzinga · 2d ago
BRIEF-Walgreens Announces New Bonuses And Rewards To Further Support And Recognize Team Members
reuters.com · 2d ago
Walgreens Boots heaps bonuses, rewards for pharmacists amid labor shortage
reuters.com · 3d ago
Walgreens to pay a $200 incentive to fully vaccinated employees
Walgreens Boots Alliance Inc. said Friday that it will provide a $200 incentive to any employee who is fully vaccinated against COVID-19 by Nov. 30. The drugstore chain said the payment will be in the form of myWalgreens cash. "Throughout the pandemic, we ...
Marketwatch.com · 3d ago
Can Walgreens (WBA) Keep the Earnings Surprise Streak Alive?
Zacks.com · 3d ago
More
Forecast
Actual (USD)
Estimate (USD)
Income StatementMore
Net Income (USD)
YoY (%)
Balance SheetMore
Total Assets (USD)
Total Liabilities (USD)
Debt to Asset (%)
Cash FlowMore
Operating (USD)
YoY (%)
Learn about the latest financial forecast of WBA. Analyze the recent business situations of Walgreens Boots through EPS, BVPS, FPS, and other data. This information may help you make smarter investment decisions.
Analyst Rating

Based on 21 analysts

Hold

Disclaimer: The analysis information is for reference only and does not constitute an investment recommendation.

Analyst Price Target
The average WBA stock price target is 52.09 with a high estimate of 68.00 and a low estimate of 40.00.
EPS
Institutional Holdings
Institutions: 1.85K
Institutional Holdings: 524.30M
% Owned: 60.61%
Shares Outstanding: 864.99M
TypeInstitutionsShares
Increased
490
20.16M
New
91
7.89M
Decreased
456
28.82M
Sold Out
93
2.88M
  • Performance
  • Asset Allocation
  • Dividend History
No Data
Industry
Drug Retailers
-3.16%
Food & Drug Retailing
-1.71%
Key Executives
Chairman/Executive Director
Stefano Pessina
Chief Executive Officer/Director
Rosalind Brewer
Chief Financial Officer/Executive Vice President
James Kehoe
Chief Operating Officer
Ornella Barra
Chief Human Resource Officer/Executive Vice President
Pamela Puryear
Executive Vice President/Chief Administrative Officer/General Counsel
Marco Pagni
Executive Vice President
Danielle Gray
Executive Vice President
John Standley
Senior Vice President/Chief Information Officer
Francesco Tinto
Senior Vice President
Jeff Gruener
Lead Director/Independent Director
William Foote
Non-Executive Director
James Skinner
Independent Director
Jose Almeida
Independent Director
Janice Babiak
Independent Director
David Brailer
Independent Director
Ginger Graham
Independent Director
Valerie Jarrett
Independent Director
John Lederer
Independent Director
Dominic Murphy
Independent Director
Nancy Schlichting
Declaration Date
Dividend Per Share
Ex-Div Date
07/13/2021
Dividend USD 0.4775
08/19/2021
04/22/2021
Dividend USD 0.4675
05/20/2021
01/28/2021
Dividend USD 0.4675
02/18/2021
10/29/2020
Dividend USD 0.4675
11/18/2020
07/08/2020
Dividend USD 0.4675
08/18/2020
04/22/2020
Dividend USD 0.4575
05/19/2020
01/30/2020
Dividend USD 0.4575
02/18/2020
10/23/2019
Dividend USD 0.4575
11/15/2019
07/10/2019
Dividend USD 0.4575
08/19/2019
04/18/2019
Dividend USD 0.44
05/17/2019
01/25/2019
Dividend USD 0.44
02/14/2019
10/24/2018
Dividend USD 0.44
11/08/2018
06/28/2018
Dividend USD 0.44
08/17/2018
04/11/2018
Dividend USD 0.4
05/17/2018
01/18/2018
Dividend USD 0.4
02/14/2018
10/24/2017
Dividend USD 0.4
11/10/2017
07/12/2017
Dividend USD 0.4
08/16/2017
04/20/2017
Dividend USD 0.375
05/16/2017
01/26/2017
Dividend USD 0.375
02/13/2017
10/12/2016
Dividend USD 0.375
11/15/2016
  • All
  • Financials
  • Insiders
More
About WBA
Walgreens Boots Alliance, Inc. is a holding company. The Company operates through three segments: Retail Pharmacy USA, Retail Pharmacy International and Pharmaceutical Wholesale. The Retail Pharmacy USA segment consists of the Walgreen Co. (Walgreens) business, which includes the operation of retail drugstores, care clinics and providing specialty pharmacy services. The Retail Pharmacy International segment consists primarily of the pharmacy-led health and beauty retail businesses and optical practices. The Pharmaceutical Wholesale segment consists of equity method investment in AmerisourceBergen. The Company's portfolio of retail and business brands includes Walgreens, Duane Reade, Boots, as well as global health and beauty product brands, including No7, NICE!, Soap & Glory, Liz Earle, Finest Nutrition, Botanics, Well Beginnings, Sleek MakeUP and YourGoodSkin.

Webull offers kinds of Walgreens Boots Alliance Inc stock information, including NASDAQ:WBA real-time market quotes, financial reports, professional analyst ratings, in-depth charts, corporate actions, WBA stock news, and many more online research tools to help you make informed decisions.

You can practice and explore trading WBA stock methods without spending real money on the virtual paper trading platform.